BioPharmSignal logoBioPharmSignal

Biotech News

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

Artivion (AORT)ArtivionEarnings

First Quarter & Recent Business Highlights: Achieved revenue of $116.3 million in the first quarter of 2026 versus $99.0 million in the first quarter of 2025, an increase of 18% on a GAAP basis and 12% on a non-GAAP constant currency basis Net income for the first quarter of 2026 was $1.4 million,

Open original release

Related news

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

PAVMPAVmed2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

ICCMIceCure Medical2026-05-12 12:30 EST

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

CVRXCVRx2026-05-11 20:05 EST

CVRx Reports First Quarter 2026 Financial and Operating Results

DNLIDenali Therapeutics2026-05-07 20:01 EST

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

SGHTSight Sciences2026-05-06 20:05 EST

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

STIMNeuronetics2026-05-05 11:50 EST

Neuronetics Reports First Quarter 2026 Financial and Operating Results

PLSEPulse Biosciences2026-05-04 11:00 EST

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

STIMNeuronetics2026-04-21 12:30 EST

Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call

View all latest news

Artivion

Artivion is a medical device company focused on cardiovascular surgery, aortic repair, and preservation technologies. Its products are used in complex cardiac and vascular procedures.

Recent company news

AORTArtivion2026-05-18 11:00 EST

Artivion Completes Acquisition of Endospan Ltd.

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

AORTArtivion2026-04-07 11:00 EST

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

AORTArtivion2026-03-03 21:10 EST

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Stock data

Close
26.10 USD
Market cap
991.26M USD
Exchange
NYSE
Sector
MedTech
Location
United States